146 related articles for article (PubMed ID: 9279941)
1. A higher rate of hyperandrogenic disorders in female-to-male transsexuals.
Bosinski HA; Peter M; Bonatz G; Arndt R; Heidenreich M; Sippell WG; Wille R
Psychoneuroendocrinology; 1997 Jul; 22(5):361-80. PubMed ID: 9279941
[TBL] [Abstract][Full Text] [Related]
2. Anthropometrical measurements and androgen levels in males, females, and hormonally untreated female-to-male transsexuals.
Bosinski HA; Schröder I; Peter M; Arndt R; Wille R; Sippell WG
Arch Sex Behav; 1997 Apr; 26(2):143-57. PubMed ID: 9101031
[TBL] [Abstract][Full Text] [Related]
3. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
Luboshitzky R; Ishai A; Shen-Or Z; Herer P
Neuro Endocrinol Lett; 2003; 24(3-4):249-54. PubMed ID: 14523365
[TBL] [Abstract][Full Text] [Related]
5. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
6. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
7. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
Abbott DH; Rayome BH; Dumesic DA; Lewis KC; Edwards AK; Wallen K; Wilson ME; Appt SE; Levine JE
Hum Reprod; 2017 Apr; 32(4):923-936. PubMed ID: 28333238
[TBL] [Abstract][Full Text] [Related]
8. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
White D; Leigh A; Wilson C; Donaldson A; Franks S
Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
[TBL] [Abstract][Full Text] [Related]
10. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
11. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
12. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
Nappi C; Farace MJ; Leone F; Minutolo M; Tommaselli AP; Montemagno U
Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
14. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
[TBL] [Abstract][Full Text] [Related]
15. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
16. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
Azziz R; Rafi A; Smith BR; Bradley EL; Zacur HA
J Clin Endocrinol Metab; 1990 Feb; 70(2):431-6. PubMed ID: 2137133
[TBL] [Abstract][Full Text] [Related]
17. 'Exaggerated adrenarche' in children presenting with premature adrenarche.
Likitmaskul S; Cowell CT; Donaghue K; Kreutzmann DJ; Howard NJ; Blades B; Silink M
Clin Endocrinol (Oxf); 1995 Mar; 42(3):265-72. PubMed ID: 7758231
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
19. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
Lobo RA; Goebelsmann U
Am J Obstet Gynecol; 1980 Nov; 138(6):720-6. PubMed ID: 6254362
[TBL] [Abstract][Full Text] [Related]
20. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
Moran C; Reyna R; Boots LS; Azziz R
Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
